EUR 22.6
(-3.21%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 23.4 Million EUR | -9.31% |
2022 | 25.81 Million EUR | 9.8% |
2021 | 23.51 Million EUR | 201.14% |
2020 | 7.8 Million EUR | -62.52% |
2019 | 20.82 Million EUR | -3.24% |
2018 | 21.52 Million EUR | -11.13% |
2017 | 24.22 Million EUR | 12.02% |
2016 | 21.62 Million EUR | 103.54% |
2015 | 10.62 Million EUR | 51.09% |
2014 | 7.03 Million EUR | -8.87% |
2013 | 7.71 Million EUR | 23.94% |
2012 | 6.22 Million EUR | -25.09% |
2011 | 8.31 Million EUR | 0.86% |
2010 | 8.23 Million EUR | 32.99% |
2009 | 6.19 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 12.36 Million EUR | 0.0% |
2023 Q4 | 11.47 Million EUR | 0.0% |
2023 FY | 23.4 Million EUR | -9.31% |
2023 Q2 | 11.93 Million EUR | 0.0% |
2022 Q2 | 13.54 Million EUR | 0.0% |
2022 Q4 | 12.26 Million EUR | 0.0% |
2022 FY | 25.81 Million EUR | 9.8% |
2021 Q2 | 11.14 Million EUR | 0.0% |
2021 Q4 | 12.36 Million EUR | 0.0% |
2021 FY | 23.51 Million EUR | 201.14% |
2020 FY | 7.8 Million EUR | -62.52% |
2020 Q2 | 2.5 Million EUR | 0.0% |
2020 Q4 | 5.29 Million EUR | 0.0% |
2019 Q2 | 10.8 Million EUR | 0.0% |
2019 FY | 20.82 Million EUR | -3.24% |
2019 Q4 | 10.02 Million EUR | 0.0% |
2018 Q2 | 10.73 Million EUR | 0.0% |
2018 Q4 | 10.79 Million EUR | 0.0% |
2018 FY | 21.52 Million EUR | -11.13% |
2017 Q2 | 10.02 Million EUR | 0.0% |
2017 FY | 24.22 Million EUR | 12.02% |
2017 Q4 | 14.2 Million EUR | 0.0% |
2016 Q2 | 7.61 Million EUR | 0.0% |
2016 Q4 | 14.01 Million EUR | 0.0% |
2016 FY | 21.62 Million EUR | 103.54% |
2015 Q4 | 5.09 Million EUR | 0.0% |
2015 Q2 | 5.52 Million EUR | 0.0% |
2015 FY | 10.62 Million EUR | 51.09% |
2014 Q2 | 3.86 Million EUR | 0.0% |
2014 Q4 | 3.16 Million EUR | 0.0% |
2014 FY | 7.03 Million EUR | -8.87% |
2013 Q4 | 4.33 Million EUR | 0.0% |
2013 FY | 7.71 Million EUR | 23.94% |
2013 Q2 | 3.38 Million EUR | 0.0% |
2012 Q2 | - EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | 6.22 Million EUR | -25.09% |
2011 FY | 8.31 Million EUR | 0.86% |
2011 Q4 | - EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2010 FY | 8.23 Million EUR | 32.99% |
2010 Q4 | - EUR | 0.0% |
2009 FY | 6.19 Million EUR | 0.0% |
2009 Q4 | - EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Cegedim SA | -7.4 Million EUR | 416.039% |
Guerbet SA | 23.86 Million EUR | 1.915% |
Nexus AG | 24.03 Million EUR | 2.588% |
Bastide Le Confort Médical SA | -900 Thousand EUR | 2701.0% |
Revenio Group Oyj | 19.1 Million EUR | -22.502% |
Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 78.803% |
Sartorius Aktiengesellschaft | 205.2 Million EUR | 88.592% |
Siemens Healthineers AG | 1.94 Billion EUR | 98.795% |
Medios AG | 18.81 Million EUR | -24.45% |
Equasens Société anonyme | 47.04 Million EUR | 50.243% |
Stratec SE | 13.06 Million EUR | -79.146% |